Letter

What happened to the polypill?

News of the polypill

BMJ 2008; 337 doi: 10.1136/bmj.a2160 (Published 20 October 2008)
Cite this as: BMJ 2008;337:a2160

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Tom Marshall, senior lecturer in public health1
  2. on behalf of Fatemeh Malekzadeh, Akram Pourshams, Mina Gharravi, Afshin Aslani, Alireza Nateghi, Mansoor Rastegarpanah, Masoud Khoshnia, G Neil Thomas, Bagher Larijani, Reza Malekzadeh, K K Cheng
  1. 1University of Birmingham, Birmingham B15 2TT
  1. T.P.Marshall{at}bham.ac.uk

    Watts asks what happened to the polypill for primary prevention of cardiovascular disease.1 We can provide an answer.

    The University of Birmingham and Tehran University of Medical Sciences have completed a randomised controlled trial of a four component …

    Access to the full text of this article requires a subscription or payment

    Subscribe

    Article access

    Article access for 1 day

    Purchase this article for £20 $30 €32*

    The PDF version can be downloaded as your personal record

    * Prices do not include VAT

    Rapid responses

    THIS WEEK'S POLL

    BMJ most popular